Diverse immunotherapies can effectively treat syngeneic brainstem tumors in the absence of overt toxicity

Schuelke, MR, Wongthida, P, Thompson, J et al. (8 more authors) (2019) Diverse immunotherapies can effectively treat syngeneic brainstem tumors in the absence of overt toxicity. Journal for ImmunoTherapy of Cancer, 7 (1). 188. ISSN 2051-1426

Abstract

Metadata

Authors/Creators:
  • Schuelke, MR
  • Wongthida, P
  • Thompson, J
  • Kottke, T
  • Driscoll, CB
  • Huff, AL
  • Shim, KG
  • Coffey, M
  • Pulido, J
  • Evgin, L
  • Vile, RG
Copyright, Publisher and Additional Information: © The Author(s). Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0) (http://creativecommons.org/licenses/by/4.0/) The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Keywords: Immunotherapy; Brainstem; Toxicity; DIPG
Dates:
  • Published: December 2019
  • Accepted: 10 July 2019
  • Published (online): 17 July 2019
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP) > Biomarkers and Therapy (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 17 Feb 2020 16:36
Last Modified: 17 Feb 2020 16:36
Status: Published
Publisher: BMJ Publishing Group
Identification Number: https://doi.org/10.1186/s40425-019-0673-2

Download

Share / Export

Statistics